Discover how overlooked gamma-delta T cells are crucial in fighting cancer, potentially enhancing immunotherapy. Learn about implications for companies like Calidi Biotherapeutics.
This news matters because it identifies a new mechanism in the immune system that could be harnessed to improve cancer treatments. For patients, this could mean more effective therapies with better outcomes. For the biotech industry, it opens up new research avenues and potential drug targets, possibly leading to innovative treatments that save lives.
